Please login to the form below
Mallinckrodt
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.
AstraZeneca forms $2bn gene silencing pact with Silence Tx
tissues. This is the second $2bn-plus alliance for Silence, coming after Irish drugmaker Mallinckrodt paid $25m upfront last year for a project that will develop siRNA drugs targeting the complement
Coronavirus disruption scuppers Curium Pharma sale
Paris-headquartered Curium was formed three years ago via the merger of CapVest’s IBA Molecular with the nuclear medicines business of Ireland-listed drugmaker Mallinckrodt.
US piles pressure on Mallinckrodt over alleged Acthar fraud
Drugmaker allegedly underpaid rebates owed to Medicaid. The US government has filed a lawsuit against Mallinckrodt, claiming that the drugmaker defrauded Medicaid by underpaying rebates owed to the federal health insurance ... The NDA approval was
Mallinckrodt reaches tentative $1.6bn opioid settlement
Mallinckrodt’s speciality US generics business – which includes its opioid drug franchise – will file for chapter 11 bankruptcy protection as part of the wide-scale agreement. ... Last September, Mallinckrodt sold off its contract development and
J&J proposes $4bn in cash to settle opioid crisis allegations
Mallinckrodt also agreed to pay $30m to settle allegations from two Ohio counties that it helped fuel the epidemic in September, with $24m in cash to be paid, and $6m donated
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Regeneron says antibody for COVID-19 could be ready this year
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- Impetus Digital Fireside Chat with Susanne Somerville of Chronicled
- Impetus Digital Fireside Chat with Bechara Saab of Mobio Interactive
- FDA delays review of Novartis’ MS drug ofatumumab
- Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma
- Q&A: Kay Wesley
PMHub
Healthcircle
We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
